SCHEMBL6901702

SCHEMBL6901702

Nc1ccc(SNC2CCN(C(=O)OCc3ccccc3)CC2)cc1

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.58
CYP2C19 P33261 1/20 0.58
NPC1 O15118 2/20 0.57
RAB9A P51151 2/20 0.57
GRIN2B Q13224 8/20 0.50
HTT P42858 1/20 0.50
CYP2D6 P10635 4/20 0.49
CYP2C9 P11712 4/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
NPSR1 Q6W5P4 1/20 0.49
ENPP2 Q13822 2/20 0.48
F13A1 P00488 1/20 0.47
TGM2 P21980 1/20 0.47
TGM1 P22735 1/20 0.47
CYP3A4 P08684 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6901635 0.86 SMN1; SMN2 (0.52) SMN1; SMN2CYP2C19NPC1RAB9AGRIN2B
SCHEMBL6899994 0.84 TGM2 (0.69) ENPP2F13A1TGM2TGM1
SCHEMBL25702011 0.82 SMN1; SMN2 (0.64) SMN1; SMN2CYP2C19NPC1RAB9AGRIN2B
SCHEMBL696467 0.80 SMN1; SMN2 (0.69) SMN1; SMN2CYP2C19NPC1RAB9AGRIN2B
SCHEMBL6901323 0.80 MEN1 (0.54) SMN1; SMN2CYP2C19NPC1RAB9AGRIN2B
SCHEMBL15747803 0.80 SMN1; SMN2 (0.64) SMN1; SMN2CYP2C19NPC1RAB9AGRIN2B
Hydrochloric Acid SCHEMBL16343926 0.79 SMN1; SMN2 (0.67) SMN1; SMN2CYP2C19NPC1RAB9AGRIN2B
Hydrochloric Acid SCHEMBL2515606 0.79 SMN1; SMN2 (0.67) SMN1; SMN2CYP2C19NPC1RAB9AGRIN2B
SCHEMBL3086491 0.79 SMN1; SMN2 (0.70) SMN1; SMN2CYP2C19NPC1RAB9AGRIN2B
SCHEMBL18632803 0.79 SMN1; SMN2 (0.62) SMN1; SMN2CYP2C19NPC1RAB9AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011060321-A1 TRANSGLUTAMINASE TG2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF CHDI, INC. (US) 2011-05-19 WO disclosed